Results 1 to 10 of about 29,333 (179)

Acetylation of PAMAM dendrimers for cellular delivery of siRNA [PDF]

open access: yesBMC Biotechnology, 2009
AbstractBackgroundThe advancement of gene silencing via RNA interference is limited by the lack of effective short interfering RNA (siRNA) delivery vectors. Rational design of polymeric carriers has been complicated by the fact that most chemical modifications affect multiple aspects of the delivery process.
Waite, Carolyn L   +3 more
openaire   +6 more sources

PAMAM dendrimers as efficient drug and gene delivery nanosystems for cancer therapy

open access: yesApplied Materials Today, 2018
Drug delivery systems for cancer chemotherapy are employed to improve the effectiveness and decrease the side-effects of highly toxic drugs. Most chemotherapy agents have indiscriminate cytotoxicity that affects normal, as well as cancer cells.
Fereydoon Abedi-Gaballu   +2 more
exaly   +2 more sources

Polyamidoamine (PAMAM) dendrimers synthesis, characterization and adsorptive removal of nickel ions from aqueous solution

open access: yesJournal of Materials Research and Technology, 2020
Nickel is a toxic metal and present in the effluents of electroplating industries. Conventional methods to remove nickel are expensive and ineffective. Heavy metals can be easily adsorbed by dendrimers.
Isra Sohail   +8 more
doaj   +2 more sources

Prevention of Synaptic Alterations and Neurotoxic Effects of PAMAM Dendrimers by Surface Functionalization

open access: yesNanomaterials, 2017
One of the most studied nanocarriers for drug delivery are polyamidoamine (PAMAM) dendrimers. However, the alterations produced by PAMAM dendrimers in neuronal function have not been thoroughly investigated, and important aspects such as effects on ...
Felipe Vidal   +8 more
doaj   +2 more sources

From Structure to Function: The Promise of PAMAM Dendrimers in Biomedical Applications

open access: yesPharmaceutics
PAMAM dendrimers are distinguished by their capacity for functionalization, which enhances the properties of the compounds they transport, rendering them highly versatile nanoparticles with extensive applications in the biomedical domain, including drug,
Said Alamos-Musre   +9 more
doaj   +2 more sources

Conjugation of Gentamicin to Polyamidoamine Dendrimers Improved Anti-bacterial Properties against Pseudomonas aeruginosa [PDF]

open access: yesAdvanced Pharmaceutical Bulletin, 2021
Purpose: This study aimed to design gentamicin-conjugated poly (amidoamine) (PAMAM) dendrimers to increase the therapeutic efficiency of gentamicin against Pseudomonas aeruginosa.
Hamed Sheykhloo   +4 more
doaj   +1 more source

Recent Advances in Preclinical Research Using PAMAM Dendrimers for Cancer Gene Therapy

open access: yesInternational Journal of Molecular Sciences, 2021
Carriers of genetic material are divided into vectors of viral and non-viral origin. Viral carriers are already successfully used in experimental gene therapies, but despite advantages such as their high transfection efficiency and the wide knowledge of ...
Piotr Tarach, A. Janaszewska
semanticscholar   +1 more source

Emerging innate biological properties of nano-drug delivery systems: A focus on PAMAM dendrimers and their clinical potential.

open access: yesAdvanced Drug Delivery Reviews, 2021
Drug delivery systems or vectors are usually needed to improve the bioavailability and effectiveness of a drug through improving its pharmacokinetics/pharmacodynamics at an organ, tissue or cellular level.
Hadeel Kheraldine   +5 more
semanticscholar   +1 more source

PAMAM dendrimers with dual-conjugated vancomycin and Ag-nanoparticles do not induce bacterial resistance and kill vancomycin-resistant staphylococci.

open access: yesActa Biomaterialia, 2021
The effective life-time of new antimicrobials until the appearance of the first resistant strains is steadily decreasing, which discourages incentives for commercialization required for clinical translation and application.
Guimei Jiang   +7 more
semanticscholar   +1 more source

Glycosylation of PAMAM Dendrimers Significantly Improves Tumor Macrophage Targeting and Specificity in Glioblastoma

open access: yesJournal of Controlled Release, 2021
Glioblastoma is among the most aggressive forms of cancers, with a median survival of just 15-20 months for patients despite maximum clinical intervention.
Rishi Sharma   +8 more
semanticscholar   +1 more source

Home - About - Disclaimer - Privacy